A detailed history of Cresset Asset Management, LLC transactions in Bio Techne Corp stock. As of the latest transaction made, Cresset Asset Management, LLC holds 212,448 shares of TECH stock, worth $15.1 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares
212,448
Previous 103,468 105.33%
Holding current value
$15.1 Million
Previous $7.98 Million 87.32%
% of portfolio
0.07%
Previous 0.05%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$65.98 - $77.09 $7.19 Million - $8.4 Million
108,980 Added 105.33%
212,448 $15 Million
Q4 2023

Feb 14, 2024

BUY
$52.83 - $78.22 $3.54 Million - $5.24 Million
66,943 Added 183.28%
103,468 $7.98 Million
Q3 2023

Nov 14, 2023

BUY
$67.52 - $89.42 $54,691 - $72,430
810 Added 2.27%
36,525 $2.49 Million
Q2 2023

Aug 14, 2023

BUY
$73.76 - $85.98 $1.29 Million - $1.5 Million
17,448 Added 95.52%
35,715 $2.92 Million
Q1 2023

May 12, 2023

BUY
$71.62 - $86.62 $1.31 Million - $1.58 Million
18,267 New
18,267 $1.36 Million
Q3 2022

Nov 14, 2022

BUY
$282.54 - $391.85 $49,161 - $68,181
174 Added 3.54%
5,089 $1.45 Million
Q2 2022

Aug 15, 2022

BUY
$322.67 - $449.65 $1.59 Million - $2.21 Million
4,915 New
4,915 $1.7 Million
Q1 2022

May 16, 2022

SELL
$353.85 - $487.79 $162,063 - $223,407
-458 Closed
0 $0
Q4 2021

Feb 10, 2022

SELL
$456.15 - $525.06 $608,504 - $700,430
-1,334 Reduced 74.44%
458 $238,000
Q3 2021

Nov 15, 2021

BUY
$444.87 - $538.88 $416,843 - $504,930
937 Added 109.59%
1,792 $868,000
Q2 2021

Aug 10, 2021

BUY
$387.35 - $450.26 $18,592 - $21,612
48 Added 5.95%
855 $386,000
Q1 2021

May 12, 2021

BUY
$314.62 - $411.0 $26,428 - $34,524
84 Added 11.62%
807 $309,000
Q4 2020

Feb 11, 2021

BUY
$246.9 - $321.87 $178,508 - $232,712
723 New
723 $230,000

Others Institutions Holding TECH

About BIO-TECHNE Corp


  • Ticker TECH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 39,222,600
  • Market Cap $2.79B
  • Description
  • Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures bi...
More about TECH
Track This Portfolio

Track Cresset Asset Management, LLC Portfolio

Follow Cresset Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cresset Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cresset Asset Management, LLC with notifications on news.